Psychiatry · Augusta, GA
NPI
1851488498
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3405 Mike Padgett Hwy
Augusta, GA, 30906
Phone (706) 792-7021
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,661
85 services
Medicare patients, 2024
30
Average age 56
Drug cost, 2024
$1.1M
1,793 prescriptions
Company payments, 2025
$2,605
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Prakash Merai was code 99213 (office e&m - established), 56 times for 15 patients. In total Prakash Merai billed 85 services in 6 codes, and Medicare paid $2,661.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 56 | 15 | $26.98 | $1,511 |
By year: 2022 $4,044 for 120 services; 2023 $3,037 for 99 services; 2024 $2,661 for 85 services.
Medicare prescription drug claims, 2024
In 2024, the drug Prakash Merai prescribed most often to Medicare patients was Haloperidol Decanoate, with 157 prescriptions and refills. In total Prakash Merai wrote 1,793 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Haloperidol Decanoate Generic | 157 | 157 | 18 | $13K |
| Trazodone Hcl Generic | 129 | 129 | 14 | $1,431 |
| Olanzapine Generic | 106 | 106 | Under 11 | $3,363 |
| Haloperidol Generic | 92 | 98 | 13 | $3,474 |
| Divalproex Sodium Er Divalproex Sodium | 92 | 92 | 12 | $6,570 |
| Divalproex Sodium Generic | 85 | 85 | Under 11 | $5,558 |
| Risperidone Generic | 82 | 82 | Under 11 | $1,584 |
| Benztropine Mesylate Generic | 81 | 81 | Under 11 | $1,057 |
| Sertraline Hcl Generic | 78 | 78 | Under 11 | $1,260 |
| Clozapine Generic | 71 | 71 | Under 11 | $6,434 |
| Invega Sustenna Paliperidone Palmitate | 69 | 69 | Under 11 | $233K |
| Abilify Maintena Aripiprazole | 47 | 47 | Under 11 | $139K |
| Quetiapine Fumarate Generic | 45 | 45 | Under 11 | $1,064 |
| Uzedy Risperidone | 43 | 51 | Under 11 | $166K |
| Lamotrigine Generic | 42 | 42 | Under 11 | $591 |
Brand drugs: - claims; generic drugs: 1,484 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Prakash Merai $2,605 ($2,605 in general payments such as food, travel and fees) from 11 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $716.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 26 | $716 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $385 |
| Alkermes, Inc. ALKS | 12 | $309 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $187 |
| Janssen Pharmaceuticals, Inc JNJ | 8 | $181 |
| Axsome Therapeutics, Inc. AXSM | 3 | $170 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $152 |
| Lundbeck LLC | 5 | $119 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $94.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.